NASDAQ:KIDS - Orthopediatrics Stock Price, Forecast & News

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

Orthopediatrics Corp (NASDAQ:KIDS) announced its earnings results on Thursday, November, 7th. The company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The firm had revenue of $20.74 million for the quarter, compared to the consensus estimate of $19.87 million. Orthopediatrics had a negative return on equity of 12.12% and a negative net margin of 15.80%. Orthopediatrics's quarterly revenue was up 31.1% on a year-over-year basis. During the same period in the prior year, the business earned ($0.15) EPS. View Orthopediatrics' Earnings History.

Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Orthopediatrics.

Orthopediatrics issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $19-19 million, compared to the consensus revenue estimate of $18.24 million.

5 Wall Street analysts have issued 12-month price targets for Orthopediatrics' stock. Their forecasts range from $44.00 to $54.00. On average, they anticipate Orthopediatrics' stock price to reach $49.00 in the next year. This suggests a possible upside of 2.1% from the stock's current price. View Analyst Price Targets for Orthopediatrics.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.

Media coverage about KIDS stock has been trending very negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Orthopediatrics earned a daily sentiment score of -3.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Orthopediatrics.

Orthopediatrics saw a decline in short interest in the month of December. As of December 13th, there was short interest totalling 947,000 shares, a decline of 11.5% from the November 28th total of 1,070,000 shares. Based on an average daily volume of 76,400 shares, the short-interest ratio is currently 12.4 days. Approximately 9.7% of the company's shares are sold short. View Orthopediatrics' Current Options Chain.

Some companies that are related to Orthopediatrics include Cantel Medical (CMD), Irhythm Technologies (IRTC), Glaukos (GKOS), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Cardiovascular Systems (CSII), AtriCure (ATRC), Silk Road Medical (SILK), Atrion (ATRI), Shockwave Medical (SWAV), Cryolife (CRY), Tactile Systems Technology (TCMD), Luminex (LMNX), Axonics Modulation Technologies (AXNX) and Orthofix Medical (OFIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Freeport-McMoRan (FCX), Akorn (AKRX), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Intel (INTC), Boeing (BA), Honeywell International (HON) and Nike (NKE).

(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

Orthopediatrics' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (4.48%) and Brasada Capital Management LP (0.06%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Kevin Unger and Mark C Throdahl. View Institutional Ownership Trends for Orthopediatrics.

KIDS stock was sold by a variety of institutional investors in the last quarter, including Brasada Capital Management LP. Company insiders that have sold Orthopediatrics company stock in the last year include David R Bailey and Mark C Throdahl. View Insider Buying and Selling for Orthopediatrics.

KIDS stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC. View Insider Buying and Selling for Orthopediatrics.

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of KIDS stock can currently be purchased for approximately $47.98.

Orthopediatrics has a market capitalization of $802.37 million and generates $57.56 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.View Additional Information About Orthopediatrics.

The official website for Orthopediatrics is http://www.orthopediatrics.com/.

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]